LPL Financial
IMRX icon

LPL Financial’s Immuneering IMRX Stock Holding History

LPL Financial’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Buy
37,030
+12,685
+52% +$64.2K ﹤0.01% 5784
2026
Q1 		$128K Sell
24,345
-4,780
-16% -$24.5K ﹤0.01% 5619
2025
Q4 		$192K Buy
29,125
+6,725
+30% +$43.2K ﹤0.01% 5459
2025
Q3 		$157K Buy
+22,400
New +$116K ﹤0.01% 5415

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

LPL Financial's IMRX Position: Q2 2026 in Review

LPL Financial increased its Immuneering (IMRX) stake by 52% in Q2 2026, buying an estimated $64.2K and bringing the position to 37,030 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #5784.

LPL Financial first reported a position in IMRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $192K in Q4 2025. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • LPL Financial held 37,030 shares of Immuneering worth $185K as of Q2 2026.
  • LPL Financial bought 12,685 Immuneering shares in Q2 2026, an estimated $64.2K.
  • Immuneering made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5784 holding.
  • LPL Financial first reported a position in Immuneering in Q3 2025 and has held it in 4 quarters since.
  • LPL Financial's Immuneering position peaked at $192K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.